Point of Care Diagnostics (POCD) Global Market - Forecast to 2023

Published by IQ4I on 30th May 2017 | Ref: 1005255 | This Report Is In Stock

$4950 | Single User
$6750 | Site License
$9000 | Enterprise License
$4950 | Single User
$6750 | Site License
$9000 | Enterprise License

Introduction

Point of care tests, also called near-patient testing or bedside testing, refers to the performance of diagnostic tests at or near the site where the patient is located and helps in obtaining accurate results in a very short period of time. It can be performed by non-laboratory personnel and the main benefit of POCT is to make tests more convenient and immediately to the patient that helps doctors/physician to receive the results quicker, enabling clinicians to support the timely diagnosis, monitoring, and treatment of patients. It can be performed by non-laboratory personnel and the results are used for clinical decision making. POCD is usually used in clinics, healthcare departments, hospitals, and patient’s homes. In hospitals, they are primarily performed in emergency departments, surgical suites, critical care units, and certain outpatient areas. POC tests can be performed by a wide variety of people can, including laboratory professionals, emergency first responders, radiologists, doctors, nurses, physician assistants, or other healthcare practitioners. They may even be done by patients, sometimes called "self-tests" or "home tests”. POCT has a range of complexity and procedures that vary from manual methodologies to automated analyzers. With the advancements in technology, POC testing analyzers are becoming smaller, faster, and more user-friendly and to achieve accuracy with increasingly smaller samples (body fluids). The point of care diagnostics global market is expected to grow at single digit CAGR to reach ,331.1 million by 2023.

The Point of care diagnostics market is segmented based on their products, technology, prescription mode, sample types, end-users, and geography. The global POCD market by products is segmented into glucose monitoring kits, infectious diseases testing kits, coagulation monitoring kits, hematology testing kits, pregnancy and fertility testing kits, cardiometabolic testing kits, tumor/cancer markers, urinalysis kits, cholesterol testing kits, drugs-of-abuse testing kits and others. The glucose monitoring kits are further segmented into self-glucose monitoring and continuous glucose monitoring kits. The Infectious diseases kits are further divided into HIV testing kits, Hepatitis testing kits, Tropical diseases testing kits, tuberculosis testing kits, Healthcare–Associated infection testing kits, respiratory infections testing kits, and others. The coagulation monitoring testing kits are further segmented into Prothrombin Time(PT/INR) Testing Kits and Activated Clotting Time(ACT/APTT) Testing Kits. The Pregnancy and Fertility Testing Kits are further segmented into Pregnancy Testing Kits and Fertility Testing Kits. The Cardiometabolic Monitoring Kits further segmented into Cardiac Markers, Blood Gas/Electrolytes Testing Kits, HBA1C Testing Kits, and LIPID Testing Kits. By technology, the POCD market is divided into a biosensor,microfluidics/lab-on-a-chip technology, PCR technology, Immunochromatographic/lateral flow technology and others. Based on prescription mode, POCD market is segmented into prescription based tests and over the counter tests. By sample types, POCD market is divided into blood, urine, saliva and others. Based on end-users, POCD market is segmented into hospitals, home healthcare, clinics. Further, the POCD global market is separated by geographical regions into North America, Europe, Asia-pacific and Rest of the World.

Table of Contents

1 EXECUTIVE SUMMARY 28

2 INTRODUCTION 33

2.1 KEY TAKEAWAYS 33

2.2 REPORT DESCRIPTION 34

2.3 MARKETS COVERED 35

2.4 STAKEHOLDERS 37

2.5 RESEARCH METHODOLOGY 37

3 MARKET OVERVIEW 46

3.1 INTRODUCTION 46

3.2 MARKET SEGMENTATION 48

3.3 FACTORS INFLUENCING MARKET 50

3.4 MARKET DYNAMICS 51

3.5 REGULATORY AFFAIRS 59

3.6 PORTER’S FIVE FORCE ANALYSIS 64

3.7 MARKET SHARE ANALYSIS 68

3.8 TECHNOLOGICAL ADVANCEMENTS 79

3.9 FUNDING SCENARIO 82

3.10 SUPPLY CHAIN ANALYSIS 84

4 POINT OF CARE DIAGNOSTICS GLOBAL MARKET, BY PRODUCTS 87

4.1 INTRODUCTION 87

4.2 GLUCOSE MONITORING KITS 90

4.3 INFECTIOUS DISEASES TESTING KITS 96

4.4 COAGULATION MONITORING KITS 115

4.5 HEMATOLOGY TESTING KITS 124

4.6 PREGNANCY AND FERTILITY TESTING KITS 126

4.7 CARDIOMETABOLIC MONITORING KITS 132

4.8 TUMOR/CANCER MARKERS 142

4.9 URINALYSIS 144

4.10 CHOLESTEROL TESTING KITS 146

4.11 DRUGS-OF-ABUSE TESTING KITS 147

4.12 OTHERS 149

4.13 GENETIC MARKERS/TESTING KITS 150

4.14 FAECAL OCCULT BLOOD TESTING KITS 152

5 POINT OF CARE DIAGNOSTICS MARKET, BY TECHNOLOGY 155

5.1 INTRODUCTION 155

5.2 BIOSENSOR TECHNOLOGY 158

5.3 IMMUNOCHROMATOGRAPHIC/LATERAL FLOW TECHNOLOGY 160

5.4 POLYMERASE CHAIN REACTION(PCR) TECHNOLOGY 162

5.5 MICROFLUIDIC/LAB-ON-A–CHIP TECHNOLOGY 164

5.6 OTHER TECHNOLOGIES 167

6 POINT OF CARE DIAGNOSTICS MARKET, BY PRESCRIPTION MODE 170

6.1 INTRODUCTION 170

7 POINT OF CARE DIAGNOSTICS MARKET, BY SAMPLE TYPE 176

7.1 INTRODUCTION 176

8 POINT OF CARE DIAGNOSTICS GLOBAL MARKET, BY END USER 187

8.1 INTRODUCTION 187

8.2 CLINICS 188

8.3 HOSPITALS 190

8.4 HOME HEALTHCARE 191

8.5 OTHER END-USERS 193

9 REGIONAL MARKET ANALYSIS 196

9.1 INTRODUCTION 196

9.2 NORTH AMERICA 198

9.3 EUROPE 217

9.4 GERMANY 230

9.5 ASIA PACIFIC 243

9.6 REST OF THE WORLD 268

10 COMPANY DEVELOPMENTS 290

10.1 INTRODUCTION 290

10.2 APPROVALS 291

10.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 304

10.4 NEW PRODUCT LAUNCH 309

10.5 ACQUISITIONS 314

10.6 OTHER DEVELOPMENTS 315

11 MAJOR COMPANIES 318

11.1 ABBOTT LABORATORIES, INC 318

11.2 ASCENSIA DIABETES CARE HOLDINGS AG. 328

11.3 BECTON DICKINSON AND COMPANY 332

11.4 BIOMERIEUX 342

11.5 DANAHER CORPORATION 355

11.6 DEXCOM INC. 368

11.7 F.HOFFMANN-LA ROCHE HOLDINGS AG 375

11.8 JOHNSON & JOHNSON 385

11.9 MEDTRONIC PLC 394

11.10 NOVA BIOMEDICAL 402

11.11 SIEMENS AG 407

11.12 THERMOFISHER SCIENTIFIC INC. 415

Additional Details

Publisher

IQ4I

Publisher Information

Reference

1005255 |

Number of Pages

423

Report Format

PDF

This report is published by IQ4I

Download Free Report Summary PDF

Point of Care Diagnostics (POCD) Global Market - Forecast to 2023 [Updated: 30-05-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.